EUVIMEDEUVIMED entdecken
Crossref

AI-driven design of antimicrobial peptide for combating resistance and infectious diseases

Insha Mehraj, Tanvir Ul Hassan Dar, Raja Aadil Hussain Bhat, Aflaq Hamid, Wajid Mohammad Sheikh, Akeel Beigh, Sahar Saleem Bhat

Pathology - Research and Practice · 2026-06 · 282 · 156445

DOI: 10.1016/j.prp.2026.156445 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathology - Research and Practice, 2026-06. Verfasst von Insha Mehraj und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Animal Biotechnology, Faculty of Veterinary Sciences & Animal Husbandry, SKUAST-K, Srinagar, Jammu and Kashmir, India; Department of Biot…. Hauptthemen laut MEDLINE: Artificial Intelligence, Drug Design, Antimicrobial Peptides, Communicable Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Department of Science and Technology, Ministry of Science and Technology, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The growing threat of antimicrobial resistance, coupled with the challenges of developing new antibiotics, demands innovative therapeutic solutions. Antimicrobial peptides (AMPs) present a promising alternative, yet their clinical application is limited by toxicity, instability, low permeability, and high production costs. To overcome these barriers, we employed artificial intelligence (AI) and machine learning (ML) to design a fifteen-amino acid peptide, LCN-15 (RWWRRKKLKAPIWVR), with a molecular weight of 2079 Da. This short cationic peptide, rich in arginine and tryptophan residues, exhibits strong membrane interaction and antimicrobial potential. Using AI-guided de novo design, we rapidly analyzed structural features, predicted biological activities, and optimized the sequence for enhanced safety and efficacy. ML-based predictive assays indicated broad functional potential, encompassing anti-microbial, anti-biofilm, anti-cancer, and anti-oxidant properties. Subsequent analysis indicated favourable safety attributes, including low toxicity, minimal hemolytic potential, and good blood brain barrier permeability. In addition, predictive models suggested potential immunomodulatory activity, indicating that LCN-15 may enhance host defense mechanisms alongside its direct anti-microbial effects. Further, to correlate our predictive modelling of LCN-15, we used melittin (GIGAVLKVLTTGLPALISWIKRKRQQ), a 26 amino-acid cationic linear AMP which is very well studied. This comprehensive in silico predictive analysis, performed prior to peptide synthesis, ensured that only the most promising designs were advanced for consideration, thereby streamlining the workflow, minimizing experimental steps, and reducing overall costs. Furthermore, the consistency between the predicted activities of melittin and its well-established in vitro properties further supports the reliability of the computational predictions.These findings position LCN-15 as a multifunctional therapeutic candidate with potential applications in managing infections, modulating immune responses, and addressing the urgent global challenge of antimicrobial resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Artificial IntelligenceDrug DesignAntimicrobial PeptidesCommunicable DiseasesAnti-Infective AgentsHumansMachine LearningAnimalsMelitten

Stichwörter der Autor:innen

AMRAnti-Microbial PeptidesDesigningEngineeringInfectious Diseases

Substanzen

Antimicrobial PeptidesAnti-Infective AgentsMelitten

Autor:innen und Institutionen

  • Division of Animal Biotechnology, Faculty of Veterinary Sciences & Animal Husbandry, SKUAST-K, Srinagar, Jammu and Kashmir, India; Department of Biotechnology, Baba Ghulam Shah Badshah University, Rajouri, Jammu and Kas…
  • Department of Biotechnology, Baba Ghulam Shah Badshah University, Rajouri, Jammu and Kashmir, India. Electronic address: tanvirulhasan@bgsbu.ac.in.
  • ICAR-Central Institute Of Coldwater Fisheries Research, Bhimtal, Naintal, India. Electronic address: bhataadil08@gmail.com.
  • Department of Plant Pathology, Sher-e Kashmir University of Agricultural Sciences and Technology of Kashmir, Shalimar, Srinagar, Jammu and Kashmir 05466, India. Electronic address: falak19@gmail.com.
  • Division of Veterinary Biochemistry, Faculty of Veterinary Sciences and Animal Husbandry, SKUAST-K, Srinagar, Jammu and Kashmir, India. Electronic address: wajidmohd984@gmail.com.
  • Division of Veterinary pathology, Faculty of Veterinary Sciences and Animal Husbandry, SKUAST-K, Srinagar, Jammu and Kashmir, India. Electronic address: BeighAB@gmail.com.

Förderung

  • Department of Science and Technology, Ministry of Science and Technology, India

Zitieren

APA

Mehraj, I., Dar, T. U. H., Bhat, R. A. H., Hamid, A., Sheikh, W. M., Beigh, A., & Bhat, S. S. (2026). AI-driven design of antimicrobial peptide for combating resistance and infectious diseases. Pathology - Research and Practice, 282, 156445. https://doi.org/10.1016/j.prp.2026.156445

Vancouver

Mehraj I, Dar TUH, Bhat RAH, Hamid A, Sheikh WM, Beigh A, et al. AI-driven design of antimicrobial peptide for combating resistance and infectious diseases. Pathology - Research and Practice. 2026;282:156445. doi:10.1016/j.prp.2026.156445

BibTeX
@article{Mehraj2026,
  author = {Mehraj, Insha and Dar, Tanvir Ul Hassan and Bhat, Raja Aadil Hussain and Hamid, Aflaq and Sheikh, Wajid Mohammad and Beigh, Akeel and Bhat, Sahar Saleem},
  title = {AI-driven design of antimicrobial peptide for combating resistance and infectious diseases},
  journal = {Pathology - Research and Practice},
  year = {2026},
  volume = {282},
  pages = {156445},
  doi = {10.1016/j.prp.2026.156445}
}
Kostenlos starten →